The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic ...

Subject matter experts share the challenges that patients face in terms of medication affordability, along with the role that ...

The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on ...

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

The company’s branded form of nadofaragene firadenovec-vncg will also be produced at a hub in Parsippany, NJ.

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of ...

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers ...